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Abstract
Background: There is a debate on whether preventive home visits to older people have any
impact. This study was undertaken to investigate whether preventive home visits by professional
health workers to older persons can postpone mortality in a Swedish context.
Method: A controlled trial in a small community in the north of Sweden.
Participants are healthy pensioners aged 75 years and over. 196 pensioners were selected as the
intervention group and 346 as the control group. The intervention, two visits per year, lasted two
years.
Results: During the intervention, mortality was 27 per 1000 in the intervention group and 48 per
1000 in the control group. The incidence rate ratio for the control group IR2000–2001 was 1,79
(95%CI = 0,94–3,40). Analysing the data with an "on treatment approach" gave a significant result,
2,31 (95%CI = 1,07–5,02) After the trial the difference between the groups disappeared.
Conclusion: Preventive home visits in a healthy older population can postpone mortality in a
Swedish context if they are carried out by professional health-workers in a structured way. When
the home visit programme ended the effect on mortality disappeared. These findings are dependent
on contextual factors that make it difficult to form general policy recommendations.
Background
Can health professionals postpone mortality in old age
with preventive home visits? According to this Swedish
trial the answer is yes. All over the world the number of
elderly people is increasing. In 2002 the world had
approximately 440 million people aged 65 years and over
(7,1%). During the coming 25 years the number of people
over 65 years is expected to double [1]. In the least devel-
oped countries of the world the ageing population is
growing at an even faster rate [2]. With a higher propor-
tion of older people worldwide it is reasonable to expect
an increase in the prevalence of illness [3] and increasing
global demands on resources for health care. To reduce
poor health in old age, methods such as screening, health
check-ups and physical training programmes are used in
OECD countries. One possible strategy to improve health
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among older people is preventive home visiting pro-
grammes (PHV). In this article we use the definition of
PHV made by van Haastregt [4] as "visits to independently
living elderly people, which are aimed at multidimen-
sional medical, functional, psychosocial, and environ-
mental evaluation of their problems and resources." The
results are specific recommendations and suggestions
aimed at reducing observed problems and preventing new
ones.
More than twenty years ago a Danish trial, the Roedovre
project [5], showed that home visits to old people reduced
utilisation of care. Significantly fewer admissions to hos-
pital and emergency medical calls were registered in an
intervention group compared to a control group. Since
this study, several researchers [4,6-9] have produced vary-
ing results. Some [5,7] argue that home visits can post-
pone functional decline or mortality. Others [9] indicate
that multidimensional programmes are inefficient when
the target group is older people at risk.
The effectiveness of PHV has been questioned in a system-
atic review, with the authors' recommendation to dis-
count these visits if the effectiveness was not improved
[4]. A meta-analysis based on 28 controlled trials con-
cluded that there was potential to reduce mortality risk
and improve functional ability through PHV[10]. There
appears to be conflicting results with respect to PHV and
mortality, possibly due to the heterogeneity of the studies.
If the comparison is restricted to similar trials with respect
to aim, age, staff and follow-ups, we find that three studies
present similar conclusions concerning mortality. The
Danish and UK trials [5,11] showed significant reductions
in mortality, while the Netherlands trial [12] showed a
non-significant reduction (17% in the control compared
with 14% in the intervention group).
In Australia and Denmark there is legislation governing
preventive home visits. In 1999 the Swedish Government
invited local authorities and primary care districts to apply
for financial support to develop models for preventive
home visits in Sweden. Twenty one projects all over Swe-
den received grants, among them Nordmaling, a rural
community with less than 8000 citizens, in the north of
Sweden. The project in Nordmaling showed that preven-
tive home visits, targeting healthy people 75 years and
older, had a positive effect on morbidity, utilisation of
care and quality of life[13]. The objective of this study was
to investigate whether PHV also postponed mortality.
Method
The home visit trial
The preventive home visits in Nordmaling were per-
formed during 2000 and 2001. When planning for the
project local pensioner associations were important col-
laborators. They influenced the content of the visits, the
employment of staff, and ethical aspects of carrying out
the visits as a controlled trial. One nurse and one care
manager were employed to carry out the project. Half of
the pensioners were assigned to each visitor. The nurse
and the care manager followed their "own" pensioners for
the duration of the programme, making visits to each pen-
sioner's home. Since the two visitors were trained in dif-
ferent occupational paradigms, it was decided that they
should continuously share knowledge and experiences
from the visits. The purpose was to bring the two visitors
closer with respect to their different backgrounds and to
give the pensioners similar advice and information.
Each pensioner was visited four times, once every six
months. Each visit lasted for 1,5 to 3 hours and followed
a structured program. According to the program general
information about physical activity, symptoms of com-
mon diseases of the elderly, influenza vaccination, diet,
and awareness of risks for fall injuries and what to do to
avoid them, were given. A questionnaire (see Additional
file 1) was completed every visit and different dimensions
of self reported health, functional ability, well-being and
social networks were recorded. The respondents usually
judged their situation on a scale with four alternatives.
The questionnaire functioned as an interview guide as
well as an evaluation instrument.
All visits
A multi dimensional questionnaire was used. A structure
of main themes was used but this did not prevent
researchers from taking into account the individual situa-
tion of each pensioner. The maintenance of the social net-
work as a tool for better health was stressed.
First visit
Focus on physical activity and discussion about risks in
the home
Second visit
Focus on preventing falls, information about influenza
vaccine and examples of activities in society suitable for
the person
Third visit
Focus on healthy food and information about diabetes
Fourth visit
Focus on knowledge about home help, long-term care,
access to health- and dental care.
No regular information from the home-visitor to the pri-
mary health care or the long-term elderly care provider
was made. Occasionally, when the senior was in need of
some kind of assistance, the home-visitor followed-upBMC Public Health 2006, 6:220 http://www.biomedcentral.com/1471-2458/6/220
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before the next visit by telephone, or extracted a promise
from the senior to contact a primary health care centre.
The visitor assessed each individual's situation and acted
accordingly. Thus a person in need of assistive devices or
drug regime review, for example, would be given informa-
tion on available solutions and followed up. Other exam-
ples of recommendations include to start the morning
with exercises in bed to reduce the risk of falling caused by
a drop in blood pressure, if that was a problem, or to par-
ticipate in suitable social activities or physical exercises, if
that was judged to be of value.
Study participants
All inhabitants in Nordmaling, 75 years or older, and liv-
ing independently without any home help or home-nurs-
ing care were eligible for the trial – in total 595 persons
(Fig 1. I). Those whose birth date was divisible by three
were assigned to the intervention (i.e. born on the 3rd,
6th, 9th etc. of any month). The remaining participants
were assigned to the control group. In the intervention
group, 49 people (Fig 1. II) were cohabiting with partici-
pants initially assigned to the control group. To avoid con-
tamination of the control group, these individuals were
also assigned to the intervention group if they were over
75 years and without home help. Thus, 249 pensioners
formed the intervention group and (Fig 1. III) were sent a
letter of invitation to the trial. 200 individuals accepted
the home visits (Fig 1. IV) but one died and three couldn't
make the time, hence there were 196 who got the visits.
The remainder of the population, 346 seniors (Fig 1. V),
formed the control group (Fig 2). Seniors in the control
group got no visits. They were not informed of the belong-
ing to any group in this trial. Anyone invited to the trial
that moved out of the municipality during the trial were
counted in the drop-out group.
A comprehensive analysis of the drop-out group was con-
ducted. An important part of this analysis was a structured
telephone interview aimed at gathering information as to
why these individuals declined to participate.
Description of the studied population Figure 1
Description of the studied population.
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The Consort E-Flowchart Figure 2
The Consort E-Flowchart.
Population in Nordmaling 
agede 75+  (n= 929  )
Excluded  (n= 334  )
  Not meeting inclusion criteria
(n=   332 )
  Refused to participate
(n=    )
  Other reasons 
(n=  2   )
Analyzed  (n=  346  )
Excluded from analysis  (n=   0  )
   Give reasons
Lost to follow-up  (n=    )
   Give reasons
Discontinued intervention
    (n=     )
    Give reasons
Allocated to the control group
(n=346     )
Lost to follow-up  (n=   0 )
   Give reasons
Discontinued intervention
    (n=  0   )
    Give reasons
Allocated to intervention group
(n=   249  )
Received allocated intervention
(n=   196  )
Did not receive allocated intervention
(n=   53 )
Give reasons
Did not want to participate (n=46)
Moved from the area (n=2)
Died before intervention (n=2)
Wanted to participate but couldn’t 
spare the time (n=3)
Analyzed  (n=  196  )
Excluded from analysis  (n=  0   )
   Give reasons
Allocation
Analysis
Follow-Up
Enrollment
Is it Randomized?
Yes
Not applicableBMC Public Health 2006, 6:220 http://www.biomedcentral.com/1471-2458/6/220
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Statistical methods and analyses
Baseline data were collected from the Swedish National
registration and the registration of patients in hospital
care made by the county council in Västerbotten. All mor-
tality data came from the Swedish national registration.
The Cohort software was used to calculate the time at risk
for each individual from the date when they entered the
study. (The software is developed by the Department of
Public Health and Clinical Medicine, Epidemiology and
Public Health Sciences, Umeå University, and it can be
obtained as freeware from the author.) Incidence rate
ratios, with the PHV group as reference group, were calcu-
lated with a confidence interval (95% CI). Calculations
were made both as "intention to treat" (ITT) and as "on
treatment" analyses. The trial period was compared with a
post-trial period starting in January 2002 and ending in
October 2004. Subgroups, based on gender and cohabita-
tion, were analysed.
Ethical approval
Informed consent was obtained from every person in the
intervention group. All participants were also invited to a
presentation of the preliminary results when the trial had
ended. Permission from the Research Ethics Committee at
Umeå University was obtained for this study (dnr 02–
445).
Results
The groups in the trial were similar with respect to gender,
age, and not having been hospitalised during 1999. The
mean age was 79 years and there were more woman than
men (Table 1). In the intervention group the proportion
of cohabitants was higher because 48 spouses initially
randomized to the control group were included in the
intervention group.
During the two years of intervention mortality was 27 per
1000 years in the intervention group and 48 per 1000
years in the control group. The incidence rate ratio IR2000–
2001, using the control group as reference, was 1,79
(95%CI = 0,94–3,40) (Table 2). Analysing the data with
an "on treatment" approach, gave a significant result, 2,31
(95%CI = 1,07–5,02) (Table 3). During the follow-up
period (2002–2004) the mortality increased in both
groups but the difference between the groups disap-
peared. The mortality in both groups was 60 per 1000
years, Subgroup differences during the intervention
period, although not statistically significant, are interest-
ing. For women the "on treatment" analysis gave an IR
2000–2001 = 3,95 (95 % CI = 0,89–17,40) and for persons
living alone an IR 2000–2001 = 6,27(95% CI = 0,83–47,26).
Discussion
The results from Nordmaling indicate that mortality is
influenced by preventive home visits. The result for the
intervention period is significant when an "on treatment"
analysis is used despite the relatively small groups. The
result also shows that both men and woman gain from
PHV, even if female mortality in general is lower. In terms
of mortality there is a tendency for single persons to gain
more from PHV than cohabitants (Fig 3.). However the
positive effect is there only as long as PHV are ongoing. Is
the effect on mortality time-limited or was compliance to
the recommendations lower when the programme of vis-
its ended? We cannot answer that question. We know that
many seniors described that the visits gave a sense of secu-
rity, a feeling of being important and they reported
improved self-rated health along the path of visits. That
could partly explain the difference in mortality patterns. It
has been shown that self-rated health is important to
maintaining good health[14].
The trial in Nordmaling was one of 21 different PHV
projects in Sweden and the results concerning health and
well-being from the other trials were also positive [15,16],
but the effect of PHV on mortality has not been measured
elsewhere in Sweden. When conducting a trial in a small
community it is important to get public support for the
idea that only some community members will potentially
benefit from the intervention. In this trial, therefore, the
local pensioners' associations were invited to discuss the
possibility of all people aged 75+ years receiving PHV in
the future. The possibility of expanding the home visit
programme to all people aged 75+ years in the commu-
nity, should the trial produce positive results, was also dis-
cussed with representatives of the municipality. The
pensioners' associations also became active partners in the
management of the trial.
Table 1: Characteristics of the three groups
Intervention group n = 196 Control group n = 346 Drop-out group n = 52 p-value
Women (%) 107 (54,6) 196 (56,5) 24 (46,2) 0,455
Mean age, year (± SD) 79,7 (± 3,91) 79,8 (± 4,30) 77,7 (± 2,95) 0,009
Proportion 75 – 80 years (%) 109 (55,6) 206 (59,5) 41 (78,8) 0,000
Cohabitants (%) 125 (63,8) 159 (45,8) no info 0,000
No hospital visit, 1999(%) 159 (81,1) 274 (79,2) 44 (84,6) 0,849BMC Public Health 2006, 6:220 http://www.biomedcentral.com/1471-2458/6/220
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All participants in the trial used regular health care. Health
care providers in primary and long-term facilities were
blinded to the trial, as far as possible. There were no dif-
ferences in access to health care or access to other activities
in society between the visited and not-visited groups.
However there might be a difference in knowledge.
The intervention group was established for this trial alone
and was not used for any additional studies or interven-
tions, therefore there was no contamination from other
activities.
The design and analysis of this kind of "real-life" interven-
tion is not self-evident. To reduce contamination between
the intervention group and the control group, the spouses
of pensioners randomized to the intervention group were
also invited to participate. As a consequence the propor-
tion of cohabitants is larger in the intervention group than
in the control group. This difference gives rise to opposite
effects. The death rates in the intervention group during
the study period can be expected to be lower because
cohabitant living is normally a protective factor. On the
other hand, our data reveals that the interventions have
had a smaller effect among cohabitants. The effects may
cancel each other out because the result, when excluding
the spouses allocated to the intervention group, due to
family affiliation and not due to birth-date did not
change. Furthermore, it is unrealistic to assume that all
members in the control group had absolutely no exposure
to the intervention [17]. Neighbours talk and friends
share experiences. This indicates that the data presented
may therefore be an underestimate.
One in five potential participants in the study declined the
invitation to participate (Figure 1). An effort was made to
telephone all 46 persons who refused to participate and
still lived in the community. Five individuals refused to
give any additional information and 16 individuals did
not answer the call. Thirteen people stated that they had
no need for a visit and four individuals gave different
Table 3: Mortality in the intervention group compared with the controls – on treatment
Year n Risk time (year) Death Death/1000 years Incident rate ratio CI (95%)
All participants
Intervention group 2000–2001 196 385 8 21 1
Control group 2000–2001 346 666 32 48 2,31 1,07–5,02
Intervention group 2002–2004 188 485 32 66 1
Control group 2002–2004 314 831 50 60 0,91 0,59–1,42
Living single
Intervention group 2000–2001 71 141 1 7 1
Control group 2000–2001 187 360 16 44 6,27 0,83–47,26
Cohabitants
Intervention group 2000–2001 125 244 7 29 1
Control group 2000–2001 159 305 16 52 1,89 0,75–4,44
Woman
Intervention group 2000–2001 107 213 2 9 1
Control group 2000–2001 195 377 14 37 3,95 0,89–17,40
Men
Intervention group 2000–2001 89 172 6 35 1
Control group 2000–2001 151 288 18 63 1,79 0,71–4,51
Table 2: Mortality in the intervention group compared with the controls – intention to treat
Year n Risk time (year) Death Death/1000 years Incident rate ratio CI (95%)
All participants
Intervention group 2000–2001 248 483 13 27 1
Control group 2000–2001 346 666 32 48 1,79 0,94–3,40
Intervention group 2002–2004 235 616 37 60 1
Control group 2002–2004 314 831 50 60 1,00 0,66–1,53
Woman
Intervention group 2000–2001 131 259 3 12 1
Control group 2000–2001 195 377 14 37 3,21 0,92–11,16
Men
Intervention group 2000–2001 117 224 10 44 1
Control group 2000–2001 151 288 18 63 1,40 0,65–3,03BMC Public Health 2006, 6:220 http://www.biomedcentral.com/1471-2458/6/220
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medical reasons for not participating. The remainder
stressed different aspects of personal autonomy such as "I
manage by myself" or "I want to have privacy". In the
drop-out group the proportion of youngest old (75–80
years) is higher than in the other groups. Admission to
hospital before the trial was less common in the drop-out
group, (Table 1) indicating that it is reasonable to expect
a lower mortality rate in the drop-out group.
Considering the circumstances described above, the best
mode of analysis is not obvious. The allocation of spouses
as well as drop-outs has probably introduced bias. One
important reason to use an "intention-to-treat" (ITT) anal-
ysis is that this analysis reflects how PHV, in this case, will
perform in a population and takes care of the selection
bias introduced by drop-outs. However, the inclusion cri-
teria used are very general and the natural selection proc-
ess is possibly more appropriate. The intervention is
offered to the all people 75 years and older living inde-
pendently, and those feeling quite healthy are likely to
reject the offer and postpone participation for some years.
Taking all into account, we have in this article decided to
present the results both as "intention to treat" and as "on
treatment" analyses. The differences in effect size and sig-
nificance level between ITT and OT most likely mirrors the
above reasoning – when the more healthy drop-outs are
included the effect decreases.
Another important question is whether the efficacy in this
trial can be transferred to effectiveness in ordinary care
activities. It may be that during this trial, the results were
influenced by the Hawthorne effect[18]. The pensioners
in the intervention group felt that they were specially
selected and appreciated being part of the PHV trial. Elton
Mayo describes this phenomenon as one possible expla-
nation for positive results. In this intervention it was desir-
able to create a Hawthorne effect, not as an explanation
for the result but as a part of the intervention itself. It was
considered beneficial for the participants to feel that they
were appreciated and had the potential to remain healthy
and secure. It is important for old people to be appreci-
ated [19] as this can influence self-rated health which in
itself can have an impact on health outcomes [20]. This
trial demonstrates the advantages of a structured home-
visit programme, when carried out as a part of the ordi-
nary health care organisation with well educated and
motivated staff.
Stuck et al conclude [6] that the number of admissions to
nursing homes is related to the number of home visits
with no less than five visits required to produce a benefi-
cial effect. The mortality rate, however, does not seem to
be affected. Van Haastregt et al find it unsuitable to use a
meta analysis approach [4], and show how different set-
tings influence the conclusions drawn. A recently pub-
lished report from WHO [21] concludes that PHV can
reduce mortality, prevent nursing home admissions and
has the potential to be cost effective. Despite these conclu-
sions the authors are very cautious regarding general pol-
icy considerations: "This review does not provide evidence
for stopping existing home-visiting programmes, but fur-
Distribution of mortality during and after the trial Figure 3
Distribution of mortality during and after the trial. (%).
Year 2000 - 2001
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ther research is required... prior to implementing new pro-
grammes."
Seldom is the content of regular primary health care and
long-time care for older people described when PHV trials
have been published. This is important if the control
group used as the reference uses the same regular services
as the intervention group. All people in Sweden have good
access to medical treatment, however preventive activities
for old people have been withdrawn over the last decade
due to lack of resources and there has been a marked
redistribution of resources to individuals with compre-
hensive care needs[22]. This implies that access to preven-
tive health care and long-term care for older persons with
fairly good health is less than several years ago. A change
in regular care available to the control-group, may alter
the result of the intervention, e.g. measured as incidence
rate ratio. It is therefore reasonable to state that a home
visit programme in Sweden is more valuable today than it
would have been a decade ago. In other countries the sit-
uation may be different. This trial shows that PHV is
favourable in the Swedish context but that it is inappropri-
ate to generalize these findings to other countries and
other contexts. While this makes it difficult to formulate
general recommendations, we believe that this trial pro-
vides sufficient evidence for implementing structured
PHV programmes in the Swedish context.
Conclusion
Preventive home-visits can postpone mortality in a
healthy older population but the mortality effect can only
be shown during the intervention period. This trial dem-
onstrates the advantages of a structured home-visit pro-
gramme, when carried out with well educated and
motivated staff.
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